naftopidil and Prostatitis

naftopidil has been researched along with Prostatitis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akasaka, T; Fujishima, M; Funaki, H; Hirano, S; Kudou, T; Ohinata, M; Suzuki, A	1
Araki, M; Chancellor, MB; Inoue, M; Kumon, H; Monden, K; Nasu, Y; Saika, T; Sasaki, K; Uehara, S; Watanabe, T	1
Cai, SL; Chen, SP; Chen, SY; Ding, Q; Gu, XJ; Huo, HX; Li, NC; Li, X; Na, YQ	1

Trials

1 trial(s) available for naftopidil and Prostatitis

Article	Year
[Clinical application of alpha1 adrenoceptor antagonist Naftopidil to the treatment of chronic non-bacterial prostatitis]. Zhonghua nan ke xue = National journal of andrology, 2006, Volume: 12, Issue:3 Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatitis	2006

Other Studies

2 other study(ies) available for naftopidil and Prostatitis

Article	Year
[Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment]. Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Chronic Disease; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Pelvic Pain; Piperazines; Prostatitis; Quality of Life; Surveys and Questionnaires; Syndrome; Time Factors	2010
Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU international, 2011, Volume: 108, Issue:2 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Biomarkers; Bodily Secretions; Enzyme-Linked Immunosorbent Assay; Epidemiologic Methods; Humans; Magnetic Field Therapy; Male; Middle Aged; Naphthalenes; Nerve Growth Factor; Pain Measurement; Piperazines; Prostate; Prostatitis; Quinolones; Treatment Outcome	2011

Article

Year

[Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].

Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:4

Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Chronic Disease; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Pelvic Pain; Piperazines; Prostatitis; Quality of Life; Surveys and Questionnaires; Syndrome; Time Factors

2010

Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.

BJU international, 2011, Volume: 108, Issue:2

Topics: Adrenergic alpha-Antagonists; Adult; Aged; Biomarkers; Bodily Secretions; Enzyme-Linked Immunosorbent Assay; Epidemiologic Methods; Humans; Magnetic Field Therapy; Male; Middle Aged; Naphthalenes; Nerve Growth Factor; Pain Measurement; Piperazines; Prostate; Prostatitis; Quinolones; Treatment Outcome

2011